Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2 Study of Loncastuximab Tesirine and Rituximab as Bridging Therapy Prior to Standard-of-care CD19 CAR T-cell Therapy in Patients With Large B-cell Lymphoma
The purpose of this clinical trial is to learn if the study treatment Loncastuximab tesirine and Rituximab is safe and efficient before standard of care chimer…
Relapsed or Refractory Large B-cell Lymphoma
University of UtahNCT06788964
Phase 2
A Phase 2 Study of Outpatient Epcoritamab as Second Line Therapy in Non-Transplant Eligible Relapsed/Refractory Large B-cell Lymphoma
The purpose of this study is to measure the efficacy of the study drug, epcoritamab, in participants with relapsed/refractory large B-cell lymphoma.
Relapsed Large B-cell LymphomaRefractory Large B-cell Lymphoma
Massachusetts General HospitalNCT06811272